Hasan Akbaba
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 14
- Lipid Membrane Structure and Behavior 4
-
- T-cell and B-cell Immunology 3
- Immune Cell Function and Interaction 3
- Immunotherapy and Immune Responses 3
- Toxin Mechanisms and Immunotoxins 3
- Co-authors
- Gülşah Erel‐Akbaba (18 shared papers)Ayşe Gülten Kantarcı (9 shared papers)Mustafa Kotmakçı (4 shared papers)Max Zinter (1 shared paper)E. Antonio Chiocca (1 shared paper)Litia Carvalho (1 shared paper)Tian Tian (2 shared papers)Bakhos A. Tannous (2 shared papers)
- Journals
- Journal of Drug Delivery Science and Technology (3 papers)ACS Omega (2 papers)Journal of Food Engineering (1 paper)European Journal of Medicinal Chemistry (1 paper)International Journal of Pharmaceutics (1 paper)
- Partner nations
- TürkiyeUnited StatesCzechia
In The Last Decade
Hasan Akbaba
34 papers receiving 572 citations
Peers
Comparison fields: 5 of 77
- Pharmaceutical Science 78
- Biomaterials 158
- Immunology 107
- Molecular Medicine 18
- Biomedical Engineering 142
Countries citing papers authored by Hasan Akbaba
This map shows the geographic impact of Hasan Akbaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hasan Akbaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hasan Akbaba more than expected).
Fields of papers citing papers by Hasan Akbaba
This network shows the impact of papers produced by Hasan Akbaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hasan Akbaba. The network helps show where Hasan Akbaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Hasan Akbaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 176 | |
| 2 | 2020 | 81 | |
| 3 | 2016 | 62 | |
| 4 | 2016 | 34 | |
| 5 | 2020 | 28 | |
| 6 | 2020 | 25 | |
| 7 | 2018 | 16 | |
| 8 | 2016 | 14 | |
| 9 | 2022 | 12 | |
| 10 | 1997 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2021 | 11 | |
| 13 | 2018 | 11 | |
| 14 | 2020 | 9 | |
| 15 | 2021 | 9 | |
| 16 | 2023 | 7 | |
| 17 | 2018 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2019 | 6 | |
| 20 | 2020 | 6 |
About Hasan Akbaba
Hasan Akbaba is a scholar working on Molecular Biology, Immunology, Pharmaceutical Science, Organic Chemistry and Biomaterials, having authored 37 papers that have together received 577 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (14 papers), Nanoparticle-Based Drug Delivery (5 papers), Advancements in Transdermal Drug Delivery (5 papers), Lipid Membrane Structure and Behavior (4 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Immunotherapy and Immune Responses (3 papers) and Toxin Mechanisms and Immunotoxins (3 papers). The work is most often cited by research in Pharmaceutical Science (78 citations), Biomaterials (158 citations), Immunology (107 citations), Molecular Medicine (18 citations) and Biomedical Engineering (142 citations). Hasan Akbaba has collaborated with scholars based in Türkiye, United States and Czechia. Frequent co-authors include Gülşah Erel‐Akbaba, Ayşe Gülten Kantarcı, Mustafa Kotmakçı, Max Zinter, E. Antonio Chiocca, Litia Carvalho, Tian Tian, Bakhos A. Tannous, Ralph Weissleder and Pierre J. Obeid. Their work appears in journals such as Journal of Drug Delivery Science and Technology, ACS Omega, Journal of Food Engineering, European Journal of Medicinal Chemistry and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.